Eli Lilly SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Eli Lilly analyses the brand by its strengths, weaknesses, opportunities & threats. In Eli Lilly SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Eli Lilly to benchmark its business & performance as compared to the competitors. Eli Lilly is one of the leading brands in the pharma and healthcare sector.

The table below lists the Eli Lilly SWOT (Strengths, Weaknesses, Opportunities, Threats), top Eli Lilly competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).

Eli Lilly SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Eli Lilly Brand Analysis
Parent Company

Eli Lilly & Co


Pharmaceutical  & chemical


Pharma and Healthcare

Tagline/ Slogan

Transforming challenges in advances


Lilly makes medicines that help people live longer, healthier, more active lives.

Eli Lilly STP

They operate in Oncology, cardiovascular diseases, diabetes, critical care, neuroscience, men’s health, and musculoskeletal segments.

Target Group

Healthcare professionals offering solutions to patients suffering from oncology, diabetes, neuroscience


Lilly makes medicines that help people live longer, healthier, more active lives.

SWOT Analysis of Eli Lilly
Eli Lilly Strengths

Below are the Strengths in the SWOT Analysis of Eli Lilly:

1. Strong capability to create strategic alliances & marketing partnerships with other corporations

2. Strong marketing ability such as 60 second commercial plot for drug Cialis

3. Well developed in house R&D capability

4. Global footprint & ability to sell drugs all over the world

5. They employ more than 7000 people in LRL spanning 50 countries
6. Products available in over 125 countries and has close to 40,000 employees

Eli Lilly Weaknesses

Here are the weaknesses in the Eli Lilly SWOT Analysis:

1. Loss of patents in US & other major markets affects performance

2. Drop sales because of new generic products

3. Eli lilly has captured fragmented market shares which prevents it from becoming market leader

Eli Lilly Opportunities

Following are the Opportunities in Eli Lilly SWOT Analysis:

1. Improvement  global living standards

2. Increasing awareness about healthcare needs

3. Global societies growing older

Eli Lilly Threats

The threats in the SWOT Analysis of Eli Lilly are as mentioned:

1. Over the years there is considerable increase in generic

2. Economic slow down

3. Increased hurdles for drug discovery & development

Eli Lilly Competition
Eli Lilly Competitors

Below are the top 7 competitors of Eli Lilly:

1. Pfizer
2. Sanofi

3. AstraZeneca

4. GlaxoSmithKline

5. Bristol Myers Squibb

6. Merck & Co Inc.

7. Roche Holding

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Eli Lilly. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:

The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin